Cadralazine

Cadralazine
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	C02DB04 (WHO) ;
Identifiers
	IUPAC name Ethoxy-N'-{6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl}carbohydrazide;
CAS Number	64241-34-5 ;
PubChem CID	2515;
ChemSpider	2420 ;
UNII	8T96I3U713;
ChEMBL	ChEMBL2106561 ;
CompTox Dashboard (EPA)	DTXSID4048725 ;
Chemical and physical data
Formula	C12H21N5O3
Molar mass	283.332 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(OCC)NNc1nnc(N(CC(O)C)CC)cc1;
	InChI InChI=1S/C12H21N5O3/c1-4-17(8-9(3)18)11-7-6-10(13-15-11)14-16-12(19)20-5-2/h6-7,9,18H,4-5,8H2,1-3H3,(H,13,14)(H,16,19) ; Key:QLTVVOATEHFXLT-UHFFFAOYSA-N ;
	(what is this?) (verify)

Cadralazine is an antihypertensive of the hydrazinophthalazine chemical class.^[1]

References

^ McTavish D, Young RA, Clissold SP (October 1990). "Cadralazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension". Drugs. 40 (4): 543–60. doi:10.2165/00003495-199040040-00005. PMID 2083513.

This antihypertensive-related article is a stub. You can help Wikipedia by expanding it.

v t e Nonsympatholytic vasodilatory antihypertensives (C02)
Nitrovasodilator (arterioles and venules)	Nitroprusside #
Hydrazinophthalazines (arterioles)	Hydralazine # Dihydralazine Endralazine Cadralazine Pildralazine
Potassium channel openers (arterioles)	Minoxidil Diazoxide
Calcium channel blockers (arterioles)	see list
^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III